• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Axovant - Articles and news items


Trial of RVT-101 in Alzheimer’s disease starts at Plymouth Science Park

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +